International experience in determining the cost-effectiveness thresholds

International experience in determining the cost-effectiveness thresholds

The article reviews international methodological guidelines, regulatory documents and existing approaches to the determination of the costeffectiveness threshold (CeT), also known as the willingness-to-pay threshold (WTP), the threshold value of the incremental cost-effectiveness ratio (ICeR), in eu...

Full description

Bibliographic Details
Main Authors:	T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2019-01-01
Series:	Фармакоэкономика
Subjects:	threshold value of the incremental cost-effectiveness ratio the willingness to pay threshold year of saved life year of saved quality life threshold value of economic efficiency wtp icer qaly lyg
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/273

Similar Items

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021-02-01)

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies
by: T. S. Teptsova, et al.
Published: (2018-11-01)

Willingness to pay for one quality-adjusted life year in Iran
by: Najmeh Moradi, et al.
Published: (2019-02-01)

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold
by: Tri Murti Andayani, et al.
Published: (2018-02-01)

An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran
by: Najmeh Moradi, et al.
Published: (2020-10-01)

On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
by: David Cameron, et al.
Published: (2018-01-01)

Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues
by: KD Kaplanov, et al.
Published: (2019-03-01)

The integrated care pathway for managing post stroke patients (iCaPPS©) in public primary care Healthcentres in Malaysia: impact on quality adjusted life years (QALYs) and cost effectiveness analysis
by: Aznida Firzah Abdul Aziz, et al.
Published: (2020-02-01)

Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry
by: KD Kaplanov, et al.
Published: (2019-09-01)

Understanding the global measurement of willingness to pay in health
by: Jean A. McDougall, et al.
Published: (2020-01-01)

How to assess the value of medicines?
by: Steven Simoens
Published: (2010-09-01)

Explaining the Saving-Investment Relationship with Threshold Effects
by: Ryan W. Herzog
Published: (2010-03-01)

METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES
by: R. I. Yagudina, et al.
Published: (2015-03-01)

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
by: N. Z. Musina, et al.
Published: (2017-05-01)

Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012
by: Nishila Moodley, et al.
Published: (2016-04-01)

Considering the societal perspective in economic evaluations: a systematic review in the case of depression
by: Juliane Andrea Duevel, et al.
Published: (2020-09-01)

Determination of the reference value of the incremental cost-efficacy and cost-utility coefficient in Russia in oncology
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Investigation of an empirical methodology for linking value of time with census tract median income
by: Stockton, William Radney
Published: (2010)

Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society
by: Stig Evensen, et al.
Published: (2019-05-01)

Comments on “Simoens, S. Health Economic Assessment: A Methodological Primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966”—New Zealand in Fact Has No Cost-Effectiveness Threshold
by: Scott Metcalfe, et al.
Published: (2010-04-01)

Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular Therapies
by: Paul Langley
Published: (2019-12-01)

PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM
by: A. M. Kalinina, et al.
Published: (2015-09-01)

A Systematic Method to Detect the Metabolic Threshold from Gas Exchange during Incremental Exercise
by: Brett A. Dolezal, Thomas W. Storer, Eric V. Neufeld, Stephanie Smooke, Chi-Hong Tseng, Christopher B. Cooper
Published: (2017-09-01)

Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria
by: Monika Russel-Szymczyk, et al.
Published: (2019-12-01)

ANALISIS KESEDIAAN MASYARAKAT UNTUK MEMBAYAR (Willingness to Pay) BIAYA PENGADAAN AIR BERSIH (PDAM) DI KOTA PEKANBARU
by: Ari Sandhyavitri, et al.
Published: (2016-07-01)

Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
by: Lux, Michael P., et al.
Published: (2014)

Cost-Utility Analysis: A Method of Quantifying the Value of Registered Nurses
by: Vanhook, Patricia M.
Published: (2007)

Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis
by: Maria V. Aviles-Blanco
Published: (2021-07-01)

Willingness to pay for orthodontic treatment in Kingdom of Saudi Arabia, Riyadh Province
by: Eman Jameel Fatani, et al.
Published: (2016-01-01)

Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept
by: Dominik J. Wettstein, et al.
Published: (2021-03-01)

Agronomic Growth Performance of Super Rice under Water-Saving Irrigation Methods with Different Water-Controlled Thresholds in Different Growth Stages
by: Chengxin Zheng, et al.
Published: (2020-02-01)

Cost-effectiveness of a hybrid emergency room system for severe trauma: a health technology assessment from the perspective of the third-party payer in Japan
by: Takahiro Kinoshita, et al.
Published: (2021-01-01)

Abandoning Eugenics and the QALY
by: Paul C Langley
Published: (2021-07-01)

Value Assessment in Cystic Fibrosis: ICER’s Rejection of the Axioms of Fundamental Measurement
by: Paul Langley
Published: (2020-05-01)

LONG-TERM ECONOMIC EFFECTIVENESS OF THE MULTIFACTORIAL CARDIOVASCULAR PREVENTION PROGRAMME IN THE CONTEXT OF PRIMARY HEALTH CARE
by: A. M. Kalinina, et al.
Published: (2013-02-01)

A comparison of methods for selecting untagged animals for breeding purposes
by: Parkes, Sally J.
Published: (2003)

THE INFLUENCE OF WEIGHT LOSS ON ANAEROBIC THRESHOLD IN OBESE WOMEN
by: Agnieszka Zak-Golab, et al.
Published: (2010-12-01)

A New Parameter Estimator for the Generalized Pareto Distribution under the Peaks over Threshold Framework
by: Xu Zhao, et al.
Published: (2019-05-01)

CORRELATION BETWEEN PURE TONE THRESHOLDS AND SPEECH THRESHOLDS
by: Lidija Ristovska, et al.
Published: (2021-09-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

Cannot write session to /tmp/vufind_sessions/sess_jui7ujpng46vb26omtnd2ktidb